Cite
HARVARD Citation
Pires da Silva, I. et al. (2022). Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Journal of clinical oncology. 40 (10), pp. 1068-1080. [Online].